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Abstract. Software development within regulated settings is becoming 
more and more common place. Compliance typically involves saying what 
you do and doing what you say. However, in some domains, especially 
safety-critical ones, it needs to be more than simply following the rules, and 
should be something which everybody in the organisation supports in their 
daily tasks. This can be difficult to achieve and requires an organisational 
transformation, but once begun, sets the foundation on which the software 
development process can evolve. 
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1. Introduction 
Many years ago there was an advertisement on Television which went something like, “If 
you had the only car in the world, you could drive where you like, but you haven‟t so you 
can‟t”. It was obviously a road safety commercial to re-enforce acceptable rules of 
driving, but this is very similar to what we are experiencing in the world of regulated 
software development today. If your application was the only software running, with no 
interaction with other systems, and no possible effect on third parties then who cares how 
you develop it? 
 
However, this is not the case for an increasing number of companies. Industries such as 
the financial services, safety-critical domains like aviation and medical devices, and 
companies listed on the U.S. stock exchange have seen the conditions under which they 
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operate change significantly in recent times. These changes have affected the software 
development processes within such companies by introducing software compliance rules. 
These additional requirements may take various forms depending on the type of 
regulations which apply. What is important to know is that they introduce some 
significant changes which not only can be time consuming and expensive for the software 
development teams, but have a wide affect within the broader organisation.  
 
Our research has shown that the process changes which must be introduced to satisfy the 
regulations, transform peoples‟ daily activities and therefore need to be given the attention 
and care due of any transformation process. The focus or intention of the regulations is 
important. A clear understanding of this will drive: the design of your new development 
processes, where a concentrated change management process will be needed, and the type 
and level of detailed evidence to be maintained for those crucial and sometimes painful 
audits. 
 
2. Research Process 
 
In this paper we have drawn on research into regulated software development from both a 
financial and safety-critical perspective. 
One author has 11 years experience working in a large US multinational (MyOrg) [1], and 
7 of those under the Sarbanes-Oxley (SOX) regulations (www.soxlaw.com). MyOrg is a 
leader in global supply chain business process management. NASDAQ listed, it has over 
25 centres in 14 countries and has a diverse and interconnected collection of information 
systems which are developed and maintained by a combination of in-house and 
outsourced personnel. By means of reflective analysis we examined the effects on the 
software development and support teams when the SOX regulations came into effect in 
2002. 
With a growing interest in modern software development methodologies (SDMs) such as 
Agile and Lean, we performed a mapping study of these SDMs within safety-critical 
regulated domains [2]. The resulting state-of-the-art gave us a solid understanding of the 
development issues in such domains as Aviation, Automotive, and Medical Devices. 
The Medical Device industry is seen as a growth area in many countries, and is fast 
developing into a race for world leadership. As an industry, which was somewhat immune 
to cost pressures, it is now feeling the effect of the demand for lower cost products. By 
means of an in-depth case study at a medical device manufacturing plant (MedTech), we 
examined the issues affecting the software development and which typically lead to the 
adoption of heavy SDMs [3]. MedTech is a US multinational with over 25,000 employees 
and develops medical solutions. A series of semi-structured interviews brought to light the 
concerns people had with the software development life-cycle (SDLC) and how the 
regulations had impacted it. 
We have synthesised this data into a model of influences which is presented in this paper. 
  
3. The Effects of Compliance 
 
The SDLC within a regulated area is reflective of a number of key influences. We 
synthesised our findings into a common model, categorising the influences into 4 groups. 
These categories together with some of their main influences are depicted in Figure 1, 
with a selection of exemplars included for each.  
 
3.1 Regulations 
At the top of Figure 1 we have the first of these contextual elements, regulations. Why do 
we have regulations and how important are they in terms of the development of medical 
device software? According to [4], regulations are simply a form of social organisation, 
and therefore supports the definition of regulations used in this study as being: “rules, 
principles, or conditions that govern procedure or behaviour” [5]. There are those who 
argue that there is too much regulation and  that not enough research has been done in 
assessing the adequacy of regulations in achieving their intended aims [4]. For example, 
regulations governing financial institutions, such as the Basel Accord [6] and the 
Sarbanes-Oxley Act [7], did not prevent the global banking crises of 2007. 
There are, however, different types or levels of regulation ranging from low (self 
regulation), medium (Government regulation), to high (Litigation) [8]. It is only when a 
lower form of regulation is seen to be ineffective is it raised to a higher level. 
Nonetheless, it is difficult to argue against high levels of regulation which aim to ensure 
human safety. For example, the standards and recommended practices issued by the 
Association for the Advancement of Medical Instrumentation (AAMI), aspire to a 
“continued increase in the safe and effective application of current technologies to patient 
care” [9], a laudable objective. While there is little debate about the merit of such 
motives, the AAMI does however have an additional objective, namely “the 
encouragement of new technologies” (Ibid). There is therefore a balance which needs to 
be struck between this drive for innovation and need for a high degree of device safety 
and the consequent higher level of regulation [10].  
Each country has its own specific regulatory requirements when it comes to medical 
device software. Within the United States it is governed by the Code of Federal 
Regulations Title 21. Within the European Union (E.U.) it is the Medical Devices 
Directive. More and more, such federal documents allow for adherence to international 
standards such as [9, 11-12], as satisfying these requirements. It is the influences, affected 
by such international standards and guidelines, which make the medical device software 
development process unique. Our research has found that medical device companies 
predominantly employ, what can be described as, heavy weight software development 
methodologies to ensure all required steps are taken to satisfy regulatory requirements.  
 
Within our model, the arrows emanating from the Regulations box are shown leading to 
the other three categories, indicating that compliance with the regulations must be 
addressed within multiple levels and contexts. 
  
 
Fig. 1. Categories of Influences on the SDLC within a Regulated Context
  
3.2 Organisation 
The term „Organisation‟ can be a nebulous term and so for clarification the following 
definition is used: “[An] organisation is a complex social system and is the sum of many 
interrelated variables. The operations of the organisation are influenced by the external 
environment of which it is part” [13]. 
The relevance within our theoretical model is that the organisation influences the software 
development process by defining development tasks and delegating roles (such as 
developers and testers), responsibilities (such as project managers and validation 
engineers), and authority (such as approvals). In addition, its relationship with the 
surrounding environment is an important aspect relevant to the model as identified by the 
link with the regulations box. The regulatory context will influence the organisation‟s 
ethos in terms of ensuring safe and secure software, the workforce‟s attitude to risk 
management, and their sense of responsibility. 
For example, within the MD regulations, the international standard ISO 13485:2003 [11] 
calls for a documented quality management system. In large companies, that will be 
satisfied at multiple levels. Firstly, the organisation may develop and publish corporate 
policies and procedures which describe the various processes at a high level. This is then 
complemented by specific standard operating procedures (SOPs) at the business unit 
level, and/or a software development process documents detailing software practices. 
Lower level processes which align with higher level ones demonstrate a coherent and 
unified approach, across the whole organisation, to addressing the regulatory 
requirements. 
The organisational guidelines and supports for the software development process often 
require significant investment. To protect that investment, an organisation will often seek 
to employ a formal software development methodology which is future proof (teachable), 
provides consistency, generates explicit deliverables, and provides an engineering-like 
development discipline [14]. The organisational influence plays a crucial role when it 
comes to the implementation of such a software development process or implementing 
changes to an existing process, for example, when entering a regulated industry. Such 
process changes may affect the way people do their jobs or indeed the job descriptions 
themselves, and since changing work practices is not a trivial undertaking, it should be 
dealt with like any organisational transformation [15], [16]. 
 
3.3 Software Management 
The software management box incorporates the overlapping activities of managing the 
tasks, resources and schedules, combined with the specific practices (many of which are 
of a technical nature) needed to perform the various activities within the SDLC. This 
category naturally influences the SDLC since it will be within these competencies, 
capabilities and situational contexts that the SDLC will need to be framed. For example, 
the technical nature of the product will automatically dictate the type of skills required 
and the type of development environment needed. The availability or lack or availability 
of these resources will shape the resulting SDLC [17]. In addition, the existing technical 
infrastructure will go some way towards assisting or hindering the adoption of a specific 
  
SDLC approach. For example a company which uses a language not conducive to an 
object oriented approach [18] (such as earlier versions of Visual basic, Fortran and 
Pascal), may have difficulty in following an SDLC which calls for such practices. 
Similarly, unless some investment is made in additional hardware and/or software, an 
SDLC which promotes test driven development [19] and continuous integration [20] is 
unlikely to be proposed where the environment is not adequately equipped. 
Different people and organisations approach project management of software 
development differently. Depending on the perceived importance of the software, for 
example is it seen as a strategic competitive advantage [21], [22], or merely an asset to be 
managed [23], [24], the SDLC will reflect this. A company which sees the software as 
being strategically important may also be more supportive of pursuing lean or agile 
approaches such as iterative development [25] and/or closer contact between developers 
and end users [26] in order to improve that key process area. 
 
3.4 People 
An obvious influence on the software development process are the people who are 
involved with it on a daily basis. There are a myriad of areas which have been studied 
over the years surrounding the issues with software development due to the human 
condition. For example the fundamental problems associated with knowledge 
management in such a specialist environment continues right up to the present day [27], 
[28], [29], [30]. Another factor is the motivation of the software developers themselves 
[31], [32], [33], something considered to be the most impactful on productivity [34]. 
Indeed unmotivated developers can be seen as sources of negative productivity and a 
liability to a project‟s success [35]. 
The effect of regulatory compliance is very notable at a personnel level as it is precisely 
the human activities that are being governed. When moving from an unregulated into a 
regulated environment, unless the work processes are already fulfilling the regulations 
(experience suggests that this is unlikely), there is a need for peoples‟ daily activities to 
change. For example, both SOX and MD regulations look for some level of independence 
in certain key areas. SOX looks for segregation of duties when it comes to code 
deployment or even access to a production system, while MD regulations expect 
independence between developers and validation engineers. The typical approaches to 
activities such as communication and knowledge transfer, where important ad hoc 
conversations go undocumented, or an approval is given verbally, are no longer 
acceptable. When people are used to operating in an environment where issues can be 
fixed “on the spot”, these tighter controls can be very frustrating for both the technical 
employee as well as for the person awaiting resolution. 
 
4. A Transformation Process 
 
In 2007 the European Medical Device Directive (MDD) expanded its definition of a MD 
to include stand alone software in its own right to be a possible MD [36]. As was the case 
when SOX was enacted in 2002, this is where a transformation process will be necessary. 
  
In other words, existing processes and work habits need to change, and as with any 
change process requires disciplined attention to some important aspects [16]. 
This transformation is not only a change in physical activities such as recording test 
results or maintaining traceability, but equally requires a change in mindset. For example, 
the MD regulations hold risk management (RM) (safety risk as opposed to, for example, 
project risk) as a critical aspect of the product development: 
“The manufacturer shall establish, document and maintain throughout the life-
cycle an ongoing process for identifying hazards associated with a medical device, 
estimating and evaluating the associated risks, controlling these risks, and 
monitoring the effectiveness of the controls” [11]. 
The words “throughout the life-cycle an ongoing process” means it is not something that 
starts and finishes during a particular phase of the life-cycle but is something that must be 
woven into the entire process. From a software point of view, RM is completely irrelevant 
without the context of the surrounding device or people and processes. A software failure 
alone cannot cause harm. It is important therefore that the interface between the software 
team and other teams, such as the hardware developers and quality engineers, supports an 
ethos of thinking about hazards in a cross functional holistic sense at all times (Figure 2).  
 
 
Fig. 2. SDLC with RM across the entire process 
 
In order to structure the discussion around such a transformation we utilise the four 
categories identified in Figure 1 and draw on specific examples for clarity. 
 
  
4.1 Organisation 
Changing work practices, in order to be compliant, requires the generation of a sense of 
urgency typical of a transformation process [37]. However, if this urgency is not 
communicated in a timely manner, it can lead to severe teething problems when it comes 
to being audited. Within MyOrg, the first dry-run SOX audit presented some non-
conformances because there was no evidence of compliance dating back to the official 
launch date. Although evidence could be collected from dates after this, the issue resulted 
in a painful retrospective evidence gathering exercise. 
Similarly, within the MD regulations, ISO 13485:2003 [11] states that management has 
the responsibility of “communicating to the organisation the importance of meeting 
customer as well as statutory regulatory requirements”. MedTech‟s approach to this was 
to develop a mandatory training schedule for all employees on the newly formed product 
development process, administered by the human resources department. 
 
Leadership is an important attribute in a transformation process. Especially within larger 
organisations, the need for a strong guiding hand is required [37]. This need manifests 
itself at a number of levels, however, certain important roles and responsibilities will be 
mandated by the regulations. SOX, for example, holds the senior executives as 
individually responsible for the accuracy of the financial reports. MD standard ISO 
13485:2003 holds “Top Management” responsible for “evidence of its commitment to the 
development and implementation of the quality management system” and for the 
implementation of an ongoing risk management process. These typically translate into the 
formation of specific roles within the company and the delegation of authority to ensure 
their implementation. MyOrg instituted a global SOX compliance officer, while MedTech 
formed a quality assurance department which took guidance from a corporate compliance 
group responsible for ensuring internal processes were compliant.  
 
A final comment from an organisational perspective is to realise the need to evolve the 
policies and procedures once the initial transformation is complete. No matter how well 
designed and executed this is, it will be received with mixed opinions. It is incumbent on 
senior management to be aware of and solicit this feedback in order to improve. Within 
MedTech, they carried out “an upgrade to the corporate process because we’ve been 
using it for almost 3 years at this stage now. So we’ve gotten feedback from the different 
sites and we’ve released a common overarching software policy that governs the whole 
corporation” (a senior software quality engineer). Similarly, within MyOrg, they 
reviewed the processes internally one year after SOX was introduced, leading to a 
revision of the process documents, thus reducing the associated overheads. 
 
4.1.1 The Bottom Line 
If the focus of a organisation is to make money [38], then the cost of operations is a 
critical concern. Compliance costs money. These costs come in many forms, such as 
employee training, longer project timelines, additional verification & validation (V&V), 
audits (internal and external), data archiving and staying on top of regulatory updates. 
  
Within MyOrg, the software development group automatically added 20% to project 
estimates to account for the extra activities. This reduced as time went on and processes 
got more embedded in daily activities but from a business management point of view 
caused some alarm as project costs jumped. MedTech had a similar experience which led 
to many projects not proceeding at all. 
The requirements around V&V, for example within the MD regulations, in addition to 
adding cost, also cause confusion. The confusion resides with the regulatory documents, 
in that they are necessarily broad based and unspecific in terms of how V&V should be 
performed [39]. In fact this is a common criticism of the regulatory documents in general: 
“I think the regulations haven’t reached full maturity in terms of what’s needed. Certainly 
the FDA regulations, the actual text of it, is a couple of paragraphs. A lot of it is 
interpretation after that” (Senior Engineer, MedTech). Because of this lack of clarity and 
the risk averse nature of the business units, there is a tendency to do too much in order to 
be compliant. Speaking about their validation process, a MedTech project leader said 
“Personally I think we over club it a lot of the time”. Not only can the physical validation 
be overdone, but the documentary evidence required around it generates a lot of concern: 
“We’re caught in this deadlock of paperwork... The physical work is costing me X, and 3 
to 4X is what it’s costing me to actually fill out the paper work to validate it”. 
While cost pressures continue to increase, this additional cost is an unwelcome burden. 
However, this reality needs to be reflected in the expectations of the business management 
teams. It also behoves the software development teams to find ways to streamline these 
new tasks to minimise cost. The following exemplifies the point: “Since [the process 
introduction] we’ve been looking and going, ‘Oh my God’, this has nearly crippled the 
business, we need to Lean it and take it all back out again” (Principle Engineer, 
MedTech). Software development techniques, such as test driven development, automated 
testing, continuous integration, and automatic document generation can aid in simplifying 
the processes.  They can support finding and eliminating defects as early as possible, and 
can also help ease the transformation process by implementing a more lean and agile 
approach [3]. 
 
4.2 Software Management 
Depending on the industry, the regulations will have different levels of tolerance to 
compliance. Moving from unregulated to regulated requires an understanding of that level 
of tolerance. Within the MD domain, for example, there is little tolerance when it comes 
to demonstrating compliance “If you’re Microsoft you can release something that has a 
tolerable quality level but it still has problems with it. Whereas in our environment it’s a 
lot more, you cannot go any further until you have done this. You must tick 100% of the 
boxes not 95% or 80%” (MedTech Senior Engineer). Within safety-critical companies, 
management therefore have little appetite when it comes to changing established 
processes for fear of falling foul of the regulators. Nevertheless, the modern business 
environment is calling for more efficient and cost effective processes, and so change is 
inevitable. 
  
To ensure compliance, a common approach to software project management is a phase-
gate process. The salient point is the identification of specific development phases with 
clearly defined entry and exit criteria. Only when these criteria have been fulfilled can you 
enter/progress to the next stage. This approach seems to be a consequence of the 
regulations “The regulations have driven us, or the interpretation of the regulations have 
driven us towards meeting particular gates or milestones or particular steps” (MedTech 
Senior Engineer). 
The regulations, however, do not prescribe any particular methodology, even though they 
may look and read like they favour such a waterfall-type approach. For example, 
ISO14971:2007 [12] states that “This standard does not require a particular software 
development life-cycle”. What this allows for then, is the potential to evolve the 
development process and look at more efficient approaches. Our research has seen that 
companies are looking to the advantages that might be gained from agile methodologies 
such as eXtreme Programming (XP) and Scrum and, consequently, finding the evolution 
of their SDLC less problematic than anticipated [2]. 
 
Evolving your company‟s software development process, typical in un-regulated 
industries, should be no different within regulated domains. In fact, we would suggest that 
the influences of the regulations lead to the adoption of inefficient development processes. 
This can be attributed to a lack of clarity/understanding and fear of non-compliance. Once 
the initial process transformation occurs and becomes embedded, we suggest that 
companies will start finding weaknesses and will need to adjust their software processes 
accordingly. These changes will be in many forms such as more effective resource 
scheduling or implementing lean and agile practices. Within MedTech, they reduced the 
time for a typical validation process by 30%: “When we started out, there were 
validations that were effectively ongoing for 6, 9 months that just got bogged down and 
ran into problems ... now we were saying we’re going to do this and we’re going to 
complete it in 3 months”. By realising that resources were being inefficiently scheduled, 
they examined ways to address it, such as load levelling. Similar to the Kanban system in 
lean manufacturing [40] and using cards to represent different activities within the 
software project,  they identified where bottlenecks were occurring: “The card represents 
something, so in my case it was representing a validation protocol or validation 
execution” (MedTech, Senior Engineer). By making the issues visible it was easier to 
discuss and address them “It was a bit like clearing the jam in the pipe. Once you got them 
moving you got a big flow, it made a big difference”. 
In addition, being a little less dogmatic when it came to fully completing documentation, 
allowed them to achieve faster prototype systems without breaching regulations: “... we 
discovered through pain that we need to give them a piece of equipment and let them run 
it for a while and they come back and tell you what they actually really want”. 
 
4.3 People 
An organisation can‟t change unless its people change [41]. One way to achieve this is to 
issue new SOPs for project activities. Before rolling these out, however, it is important for 
  
employees to be brought up to speed on why there is a need for change and how the new 
SOPs satisfy that need. If this is not clearly enunciated then people may look for shortcuts. 
As a software developer at MedTech put it: “Before, we thought the system wasn’t great 
and this [the new process] came along which probably was worse. I don’t know how this 
came about”. This lack of clarity/buy in can result in short cutting or working outside the 
defined process: “You find that there’s an awful lot of background work done before we 
start the development proper...We officially don’t know about that” (Senior Software 
Quality Engineer, MedTech). 
 
A further difficulty with transforming work practices is coping with legacy systems. Older 
products, developed using previous processes and practices, may not be suitably designed 
or have available the requisite artefacts to suit the new process. In this case, software 
modifications may have to be performed differently depending on the project. In addition, 
if an employee is assigned only to such legacy systems, then, despite having been fully 
trained, they get very little exposure to the new processes and are potential liabilities if 
assigned to projects using the new approach. As stated by a MedTech software developer 
about the new process: “It’s 2 years here in [MedTech] that they’ve started doing it. I 
actually haven’t worked on a project yet, in the development phase that has used it”. 
 
Transforming employee work practices is therefore a protracted affair and requires careful 
implementation and monitoring until the practices start to get embedded: “Once you get to 
know what you need, and the order of things, after that period of time it becomes second 
nature” (MedTech Software Developer). 
 
5. Discussion and Recommendations 
 
Regulatory compliance from a software development perspective can be daunting for a 
company which is unfamiliar with it. The effects of regulation are widespread within an 
organisation and, due to the inexact nature of the regulatory documents, compliance can 
lead to inefficient and heavy development lifecycles. 
This of course does not have to be the case. It is important to really understand the 
intention of the regulations, and once that is crystal clear, define the processes 
accordingly. We should remember that the people best suited to determining how to 
achieve the objectives of the regulations are the people who work in these specific 
contexts.  
Each company is different and so a one-size-fits-all approach will not work. Rolling out 
an umbrella policy or procedure across an entire organisation will lead to inefficient work 
practices. Even within companies, different departments will need to have flexibility in 
how they shape their processes. For example, the research and development department 
needs to be free to innovate without getting bogged down in red tape. In addition, because 
the software development process is a collaborative process, the overlapping between 
departments needs to be smooth. 
  
We should remember that many of the activities mandated by the regulations are probably 
already being performed to some degree. There is nothing ground breaking in what they 
look for, just a more robust method of ensuring the right things are happening. Becoming 
compliant therefore requires a careful transformation process which takes a multi-layered 
view. Once this initial transformation effort happens, the way is paved for an 
improvement process which evolves the SDLC. 
 
We conclude with a series of recommended steps, shown in Figure 3, which can assist the 
successful introduction of regulatory compliant software development processes within a 
medical device organisation. 
 
  
 
Fig. 3. Suggested steps for regulated process implementation 
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